Research ArticleArticle
The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example
Lene Terslev, Esperanza Naredo, Helen I. Keen, George A.W. Bruyn, Annamaria Iagnocco, Richard J. Wakefield, Philip G. Conaghan, Lara J. Maxwell, Dorcas E. Beaton, Maarten Boers and Maria-Antonietta D’Agostino
The Journal of Rheumatology March 2019, jrheum.181158; DOI: https://doi.org/10.3899/jrheum.181158
Lene Terslev
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Esperanza Naredo
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Helen I. Keen
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
George A.W. Bruyn
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Annamaria Iagnocco
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Richard J. Wakefield
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Philip G. Conaghan
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Lara J. Maxwell
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Dorcas E. Beaton
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Maarten Boers
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Maria-Antonietta D’Agostino
From the Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet, Copenhagen, Denmark; Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz; Universidad Autónoma de Madrid, Madrid, Spain; Department of Rheumatology, University of Perth, Perth, Australia; Department of Rheumatology, MC Groep Hospitals, Lelystad; Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands; Dipartimento di Scienze Cliniche e Biologiche (DSCB) Università degli Studi di Torino, Medicina Fisica Riabilitativa Universitaria (MFRU) Città della Salute e della Scienza, Turin, Italy; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; NIHR Leeds Biomedical Research Centre, Leeds, UK; University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute, Ottawa; Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Rheumatology Department, AP-HP, Hôpital Ambroise Paré, Boulogne-Billancourt; INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines, Montigny Les Bretonneux, France. PGC is supported in part by the UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the Department of Health. L. Terslev, MD, PhD, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet; E. Naredo, MD, Department of Rheumatology, Bone and Joint Research Unit, Hospital Universitario Fundación Jiménez Díaz, IIS Fundación Jiménez Díaz, and Universidad Autónoma de Madrid; H.I. Keen, MD, PhD, Department of Rheumatology, University of Perth; G.A. Bruyn, MD, PhD, Department of Rheumatology, MC Groep Hospitals; A. Iagnocco, MD, DSCB Università degli Studi di Torino, MFRU Città della Salute e della Scienza; R.J. Wakefield, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; L.J. Maxwell, PhD, University of Ottawa and Centre for Practice-Changing Research, Ottawa Hospital Research Institute; D.E. Beaton, PhD, Institute for Work and Health and Institute for Health Policy Management and Evaluation, University of Toronto; M. Boers, MD, PhD, Department of Epidemiology and Biostatistics, and Amsterdam Rheumatology and Immunology Center, Amsterdam UMC, Vrije Universiteit; M.A. D’Agostino, MD, PhD, Rheumatology Department, AP-HP, Hôpital Ambroise Paré, and INSERM U1173, Labex Inflamex, Université Versailles St-Quentin en Yvelines. Address correspondence to Prof. M.A. D’Agostino, Rheumatology Department, Ambroise Paré Hospital, 9 avenue Charles de Gaulle, 92100 Boulogne-Billancourt, France. E-mail: maria-antonietta.dagostino@apr.aphp.fr. Accepted for publication January 31, 2019.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example
Lene Terslev, Esperanza Naredo, Helen I. Keen, George A.W. Bruyn, Annamaria Iagnocco, Richard J. Wakefield, Philip G. Conaghan, Lara J. Maxwell, Dorcas E. Beaton, Maarten Boers, Maria-Antonietta D’Agostino
The Journal of Rheumatology Mar 2019, jrheum.181158; DOI: 10.3899/jrheum.181158
The OMERACT Stepwise Approach to Select and Develop Imaging Outcome Measurement Instruments: The Musculoskeletal Ultrasound Example
Lene Terslev, Esperanza Naredo, Helen I. Keen, George A.W. Bruyn, Annamaria Iagnocco, Richard J. Wakefield, Philip G. Conaghan, Lara J. Maxwell, Dorcas E. Beaton, Maarten Boers, Maria-Antonietta D’Agostino
The Journal of Rheumatology Mar 2019, jrheum.181158; DOI: 10.3899/jrheum.181158